| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |